Delivery Order SPE2DB25D7056-SPE2DB25FTMUK
Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of ACTIVASE 50 MG VIALS to the Defense Logistics Agency (DLA), a Defense agency. The $5,729.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 7, 2024 and was awarded on November 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of ACTIVASE 50 MG VIALS to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $15,151.20. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 6, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime...
- This federal contract award is for the delivery of ACTIVASE 100 MG VIALS to the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,267.71, was awarded on May 8, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order under the Defense Logistics Agency's Indefinite Delivery Contract (IDC) with Amerisourcebergen, which has a total potential value of up to...
- This federal contract award, valued at $23,241.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ACTIVASE 100 MG VIALS, with a period of performance through March 1, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award is for the delivery of ACTIVASE 100 MG VIALS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $31,043.61 and a completion date of February 1, 2024. This is a delivery order contract with a firm-fixed-price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a key vendor...
- This federal contract award is for the delivery of 50 mg vials of the medication ACTIVASE, valued at $2,967.97. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of 50 mg vials of the pharmaceutical drug ACTIVASE, awarded to prime contractor Amerisourcebergen Drug Corp. The $3,032.04 fixed-price delivery order contract has a completion date of July 10, 2025 and was issued by the Defense Logistics Agency (DLA), which serves as a critical supplier of medical and pharmaceutical products to federal agencies. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,967.98 firm fixed-price contract is for the supply of 4568791017 ACTIVASE 50 MG VIALS, a medication used in medical treatments. The contract has a performance period through July 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is for the delivery of ACTIVASE 50 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,864.71, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of medical...
- This federal contract award, with a ceiling value of $24,939.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTIVASE 100 MG VIALS, a specialized pharmaceutical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....